WELCH DANIEL G
SEC insider (Form 3/4/5 filer). CIK 0001206199. Director at Structure Therapeutics Inc. (GPCR) and 2 other issuers. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies WELCH DANIEL G has filed insider reports for
- Structure Therapeutics Inc. (GPCR): Director
- Ultragenyx Pharmaceutical Inc. (RARE): Director
- PROTHENA CORP PUBLIC LTD CO (PRTA): Director
WELCH DANIEL G
CIK: 0001206199
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 17, 2026GPCR
Structure Therapeutics Inc.
AwardDirectShare Option (right to buy)
39.5K shares- - May 15, 2026PRTA
PROTHENA CORP PUBLIC LTD CO
AwardDirectStock Option (Right to Buy)
27K shares- - May 14, 2026RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect7.8K shares- - Jun 23, 2025GPCR
Structure Therapeutics Inc.
AwardDirectShare Option (right to buy)
51.8K shares- - May 15, 2025RARE
Ultragenyx Pharmaceutical Inc.
AwardDirect5.7K shares- - May 14, 2025PRTA
PROTHENA CORP PUBLIC LTD CO
AwardDirectStock Option (Right to Buy)
20.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  GPCR Structure Therapeutics Inc. | Award Share Option (right to buy) | 39,453 | - | - | Direct |
| May 15, 2026 |  PRTA PROTHENA CORP PUBLIC LTD CO | Award Stock Option (Right to Buy) | 27,000 | - | - | Direct |
| May 14, 2026 |  RARE Ultragenyx Pharmaceutical Inc. | Award | 7,751 | - | $0 | Direct |
| Jun 23, 2025 | GPCR Structure Therapeutics Inc. | Award Share Option (right to buy) | 51,804 | - | - | Direct |
| May 15, 2025 | RARE Ultragenyx Pharmaceutical Inc. | Award | 5,740 | - | - | Direct |
| May 14, 2025 | PRTA PROTHENA CORP PUBLIC LTD CO | Award Stock Option (Right to Buy) | 20,183 | - | - | Direct |
1-6 of 6 transactions